文献速递心力衰竭与心肌病心律失常

西雅图心衰与比例风险模型预测ICD获益

Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

基于NCDR注册数据,比较98,846例心衰患者(87,914例植入ICD,10,932例未植入)的5年生存,SHFM与全因死亡率强相关,SPRM可区分ICD的生存获益,两模型联合可识别从一级预防ICD中获益可能性较低的患者。

要点

  • SHFM与心衰患者全因死亡率强相关(p<0.0001)。
  • SPRM五分位第5组患者ICD降低死亡风险的幅度约为第1组的2倍。
  • SHFM预测年死亡率≤5.7%且SPRM预测猝死风险低于中位数者,ICD未显著降低死亡率。

核心结论

  • SHFM在含ICD与不含ICD的大队列中预测全因死亡率,SPRM可区分并校准ICD的潜在获益,两模型联合可识别从一级预防ICD中生存获益可能性较低的患者。

研究设计与样本

  • 来自国家心血管数据注册(NCDR)的98,846例心衰患者(87,914例植入一级预防ICD,10,932例未植入ICD),采用多变量Cox比例风险回归比较5年生存。

主要发现

  • SHFM与全因死亡率强相关(p<0.0001)。
  • ICD与SPRM交互作用显著(p<0.0001):SPRM五分位第5组患者ICD降低死亡风险的幅度约为第1组患者的2倍(校正HR 0.602;95%CI 0.537-0.675 vs. HR 0.793;95%CI 0.736-0.855)。
  • SHFM预测年死亡率≤5.7%的患者中,SPRM预测猝死风险低于中位数者ICD未显著降低死亡率(校正ICD HR 0.921;95%CI 0.787-1.08;p=0.31),而SPRM高于中位数者获益最大(校正HR 0.599;95%CI 0.530-0.677;p<0.0001)。

关键数值与推荐

  • SPRM五分位第5组校正HR 0.602(95%CI 0.537-0.675),第1组校正HR 0.793(95%CI 0.736-0.855)。
  • SHFM预测年死亡率≤5.7%且SPRM低于中位数:校正ICD HR 0.921(95%CI 0.787-1.08;p=0.31)。
  • SHFM预测年死亡率≤5.7%且SPRM高于中位数:校正HR 0.599(95%CI 0.530-0.677;p<0.0001)。

临床怎么用

  • SHFM可用于心衰患者全因死亡风险预测,SPRM可辅助评估ICD的潜在生存获益。
  • 两模型联合可识别从一级预防ICD中生存获益可能性较低的患者。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent clinical trials highlight the need for better models to identify patients at higher risk of sudden death. OBJECTIVES: The authors hypothesized that the Seattle Heart Failure Model (SHFM) for overall survival and the Seattle Proportional Risk Model (SPRM) for proportional risk of sudden death, including death from ventricular arrhythmias, would predict the survival benefit with an implantable cardioverter-defibrillator (ICD). METHODS: Patients with primary prevention ICDs from the National Cardiovascular Data Registry (NCDR) were compared with control patients with heart failure (HF) without ICDs with respect to 5-year survival using multivariable Cox proportional hazards regression. RESULTS: Among 98,846 patients with HF (87,914 with ICDs and 10,932 without ICDs), the SHFM was strongly associated with all-cause mortality (p < 0.0001). The ICD-SPRM interaction was significant (p < 0.0001), such that SPRM quintile 5 patients had approximately twice the reduction in mortality with the ICD versus SPRM quintile 1 patients (adjusted hazard ratios [HR]: 0.602; 95% confidence interval [CI]: 0.537 to 0.675 vs. 0.793; 95% CI: 0.736 to 0.855, respectively). Among patients with SHFM-predicted annual mortality ≤5.7%, those with a SPRM-predicted risk of sudden death below the median had no reduction in mortality with the ICD (adjusted ICD HR: 0.921; 95% CI: 0.787 to 1.08; p = 0.31), whereas those with SPRM above the median derived the greatest benefit (adjusted HR: 0.599; 95% CI: 0.530 to 0.677; p < 0.0001). CONCLUSIONS: The SHFM predicted all-cause mortality in a large cohort with and without ICDs, and the SPRM discriminated and calibrated the potential ICD benefit. Together, the models identified patients less likely to derive a survival benefit from primary prevention ICDs.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Bilchick KC, Wang Y, Cheng A, et al. Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators. J Am Coll Cardiol. 2017. PMID: 28545633. doi:10.1016/j.jacc.2017.03.568

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。